{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:02:24Z","timestamp":1771419744161,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pseudomyogenic hemangioendothelioma (PHE) is a rare vascular neoplasm of intermediate malignancy that predominantly affects the limbs and trunk of young adults. Genital localization, particularly penile involvement, is exceptionally uncommon and may lead to diagnostic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 29-year-old man presented with a painful, ulcerative lesion on the ventral prepuce that had been present for 5\u202fyears. He initially underwent circumcision, and histopathologic evaluation of the surgical specimen suggested an undifferentiated malignant neoplasm. Despite surgery, symptoms persisted. Three months later, magnetic resonance imaging (MRI) revealed a penile mass infiltrating the corpora cavernosa, corpus spongiosum, and glans. Subsequent histopathologic re-evaluation with immunohistochemistry demonstrated co-expression of cytokeratins and endothelial markers (CD31, ERG), establishing the diagnosis of PHE. The tumor showed perineural and intravascular invasion with positive surgical margins. Given the extent of local disease and the complex anatomic location, a multidisciplinary team evaluated wide local excision, including the possibility of partial penectomy, versus systemic targeted therapy. The patient ultimately underwent partial penile resection, resulting in marked improvement in pain and overall clinical status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Penile PHE can mimic other spindle cell neoplasms, necessitating immunohistochemistry for definitive diagnosis. Surgery with negative margins remains the mainstay of treatment, though it may compromise function in genital sites. Targeted therapies directed at FOSB-related molecular pathways may benefit from unresectable or multifocal disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There are only a limited number of cases reported worldwide of this rare neoplasm, and to our knowledge this represents the first reported case from Ecuador and the first from Latin America involving this anatomic site. It highlights the tumor\u2019s diagnostic complexity, potential for aggressive local behavior, and the importance of multidisciplinary management and long-term surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1777602","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:04:46Z","timestamp":1771416286000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Penile pseudomyogenic hemangioendothelioma: a rare case report with clinicopathologic features and multidisciplinary management"],"prefix":"10.3389","volume":"13","author":[{"given":"Cecilia","family":"Carri\u00f3n","sequence":"first","affiliation":[{"name":"Pathology Department, SOLCA Quito","place":["Quito, Ecuador"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Departamento de Patolog\u00eda, Universidad Central del Ecuador","place":["Quito, Ecuador"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Moreira","sequence":"additional","affiliation":[{"name":"Departamento de Patolog\u00eda, Universidad Central del Ecuador","place":["Quito, Ecuador"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon","family":"Arias-Intriago","sequence":"additional","affiliation":[{"name":"Pathology Department, SOLCA Quito","place":["Quito, Ecuador"]},{"name":"One Health Research Group, Universidad de las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan S.","family":"Izquierdo-Condoy","sequence":"additional","affiliation":[{"name":"One Health Research Group, Universidad de las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00428-024-03944-z","article-title":"Pseudomyogenic hemangioendothelioma presenting as a penile lesion","volume":"485","author":"Youssef","year":"2024","journal-title":"Virchows Arch"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/his.14697","article-title":"Primary pseudomyogenic haemangioendothelioma of the testis with a novel POTEI::FOSB gene fusion","volume":"81","author":"Gersmann","year":"2022","journal-title":"Histopathology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13000-023-01309-9","article-title":"Clinicopathological study of pseudomyogenic hemangioendothelioma","volume":"18","author":"Yang","year":"2023","journal-title":"Diagn Pathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13000-019-0857-6","article-title":"A rare case of pseudomyogenic hemangioendothelioma (PHE)\/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature","volume":"14","author":"Ge","year":"2019","journal-title":"Diagn Pathol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.5021\/ad.2020.32.5.426","article-title":"A case of pseudomyogenic hemangioendothelioma of the lower extremity","volume":"32","author":"Choi","year":"2020","journal-title":"Ann Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/jcp-2023-208931","article-title":"New kids on the block: FOS and FOSB gene","volume":"76","author":"Cordier","year":"2023","journal-title":"J Clin Pathol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/10668969221101867","article-title":"Immunohistochemistry for FOSB and FOS is a useful ancillary tool in the diagnosis of epithelioid hemangioma but there are pitfalls in interpretation including expression in other vascular lesions","volume":"31","author":"Tsui","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/PAS.0000000000000795","article-title":"FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma","volume":"41","author":"Hung","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1186\/s12885-019-6072-8","article-title":"Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report","volume":"19","author":"Otani","year":"2019","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/ddg.15353","article-title":"Pseudomyogenic hemangioendothelioma in the external genitalia","volume":"22","author":"Zhou","year":"2024","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.prp.2015.02.003","article-title":"Penile pseudomyogenic hemangioendothelioma\/epithelioid sarcoma-like hemangioendothelioma with a novel pattern of SERPINE1-FOSB fusion detected by RT-PCR \u2013 report of a case","volume":"211","author":"Ide","year":"2015","journal-title":"Pathol Res Pract"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1186\/s12885-025-14376-6","article-title":"The efficacy and safety of gemcitabine and docetaxel in pseudomyogenic hemangioendothelioma: a multi-center experience","volume":"25","author":"Cai","year":"2025","journal-title":"BMC Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13569-015-0037-8","article-title":"Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma","volume":"5","author":"Joseph","year":"2015","journal-title":"Clin Sarcoma Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e25250","DOI":"10.7759\/cureus.25250","article-title":"Pazopanib as treatment option for pseudomyogenic hemangioendothelioma: a case report","volume":"14","author":"Alhanash","year":"2022","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1158\/1078-0432.ccr-17-3512","article-title":"Telatinib is an effective targeted therapy for pseudomyogenic hemangioendothelioma","volume":"24","author":"Van IJzendoorn","year":"2018","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13000-019-0846-9","article-title":"Primary pseudomyogenic hemangioendothelioma of the vulva: a rare location for a rare entity","volume":"14","author":"Sun","year":"2019","journal-title":"Diagn Pathol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e26781","DOI":"10.1002\/pbc.26781","article-title":"Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma","volume":"65","author":"Gabor","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1097\/MPH.0000000000000778","article-title":"Everolimus for treatment of pseudomyogenic hemangioendothelioma","volume":"39","author":"Ozeki","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.21873\/cgp.20134","article-title":"Fusion of the genes WWTR1 and FOSB in pseudomyogenic hemangioendothelioma","volume":"16","author":"Panagopoulos","year":"2019","journal-title":"Cancer Genomics Proteomics"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1097\/PAS.0000000000001147","article-title":"Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions","volume":"42","author":"Agaram","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/PAS.0b013e3181ff0901","article-title":"Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior","volume":"35","author":"Hornick","year":"2011","journal-title":"Am J Surg Pathol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1777602\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:04:47Z","timestamp":1771416287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1777602\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":21,"alternative-id":["10.3389\/fmed.2026.1777602"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1777602","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1777602"}}